NICHOLAS WINN: Open Payments
NPI 1790295095 · ABERDEEN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 34 payments from 11 companies in 2025. Trend: 2023 $414 · 2024 $706 · 2025 $489
Food & beverage: $389Education: $100
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $170 |
| Janssen Biotech, Inc. | 1 | $100 |
| LEO Pharma Inc. | 2 | $43 |
| ABBVIE INC. | 2 | $38 |
| Galderma Laboratories, L.P. | 2 | $32 |
| Biofrontera Inc. | 1 | $25 |
| Organon LLC | 2 | $20 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $15 |
| GENZYME CORPORATION | 1 | $15 |
Products named: COSENTYX, TREMFYA, ADBRY, SKYRIZI, AMELUZ, Winlevi, NEMLUVIO, AKLIEF.
Industry payments across ID — which companies pay providers there.
